World: Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter✕

Date Range

Sector

Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

biotech-investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors

psychedelics-investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

psychedelics-investing
Solvonis Therapeutics (None)

U.S. Patent allowance received for PTSD discovery programme

psychedelics-investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

psychedelics-investing
Invion Limited (IVX:AU)

Hanlim & Korean Government Fund Pathway to Clinical Trial

biotech-investing
InMed Pharmaceuticals (INM)

InMed Announces Results of 2025 Annual General and Special Meeting

pharmaceutical-investing
InMed Pharmaceuticals (INM)

InMed Provides Update on BayMedica Commercial Business

pharmaceutical-investing
Invion Limited (IVX:AU)

Invion Secures Expanded Photosoft Global Exclusive License

biotech-investing
Cardiol Therapeutics (CRDL:CA)

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

biotech-investing

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

pharmaceutical-investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

biotech-investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

pharmaceuticals-investing

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

biotech-investing
Invion Limited (IVX:AU)

Appendix 4C and Quarterly Activities Report - September 2025

biotech-investing
Solvonis Therapeutics (None)

Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

pharmaceutical-investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027

biotech-investing
Invion Limited (IVX:AU)

Funded Collaboration Agreement with Protect Animal Health

biotech-investing
Cardiol Therapeutics (CRDL:CA)

Canadian Investment Regulatory Organization Trade Resumption - CRDL

biotech-investing

Latest press releases News

More press releases News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES